Showing results (41-50 of 81) with videos related to
Sort By:
Pageof 9
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 1, 1993
The dosimetry of iodine-123-labeled TISCH: a SPECT imaging agent for the D1 dopamine receptorP D Mozley, X Zhu, H F Kung, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 1, 1996
Dosimetry of an iodine-123-labeled tropane to image dopamine transportersP D Mozley, J B Stubbs, H J Kim, et al.The American Journal of Psychiatry|April 1, 1991
Relations among clinical scales in schizophreniaR E Gur, P D Mozley, S M Resnick, et al.Parkinsonism & Related Disorders|July 21, 2004
Diagnostic accuracy of [99mTc]TRODAT-1 SPECT imaging in early Parkinson's diseaseK L Chou, H I Hurtig, M B Stern, et al.Brain and Cognition|April 1, 1997
Lateralized changes in regional cerebral blood flow during performance of verbal and facial recognition tasks: correlations with performance and "effort"R C Gur, J D Ragland, L H Mozley, et al.Synapse (New York, N.Y.)|February 1, 1997
P-[18F]-MPPF: a potential radioligand for PET studies of 5-HT1A receptors in humansC Y Shiue, G G Shiue, P D Mozley, et al.Archives of General Psychiatry|November 1, 1991
Volunteers for biomedical research. Recruitment and screening of normal controlsD L Shtasel, R E Gur, P D Mozley, et al.The American Journal of Psychiatry|March 1, 1994
Clinical subtypes of schizophrenia: differences in brain and CSF volumeR E Gur, P D Mozley, D L Shtasel, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 1, 1995
Dosimetry of a D2/D3 dopamine receptor antagonist that can be used with PET or SPECTP D Mozley, J B Stubbs, H J Kim, et al.European Journal of Nuclear Medicine|April 1, 1997
Relationship between clinical features of Parkinson's disease and presynaptic dopamine transporter binding assessed with [123I]IPT and single-photon emission tomographyK Tatsch, J Schwarz, P D Mozley, et al.Pageof 9